Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $181.05 | Total: $905.25 |
| 1 | 10 | $153.36 | Total: $1,533.60 |
| 1 | 25 | $129.93 | Total: $3,248.25 |
| 1 | 50 | $110.76 | Total: $5,538.00 |
| 1 | 100 | $95.85 | Total: $9,585.00 |
Overview
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
Chemical Properties
| Molecular Formula | C24H29FN4O2 |
| Molecular Weight | 424.51 |
| CAS Numbers | 1032265-57-8 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1C(=C2C3=C(C(C(NCCN(CC)CC)=O)=C(C)N3)CCC2)C=4C(N1)=CC=C(F)C4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Shao F, et al. Simultaneous quantification of tafetinib [SIM010603], a novel potent inhibitor of receptor tyrosine kinase, and its major metabolite in dog plasma by HPLC-ESIMSMS and its application to a pharmacokinetic study. J Pharm Biomed Anal. 2013 Jul-Aug;81-82 50-5.